Global Village
Asociación Española de BioEmpresas
| Country: | España |
| Global Village: | Delegation of Spain (ES) |
| Companies: | 3PBiovian Almirall AseBio Basque Health Cluster BeCytes Biotechnologies Bflow Biobide Bioga Bioingenium CZ Vaccines S.A.U. Diversa Technologies Fundación Medina GalChimia Gate2 Brain Innoprot Liberabio ONIRIA THERAPEUTICS, SL Oryzon SPECIFIC PIG SL (SPECIPIG) TAD |
| Roundtable discussion: | Monday, April 22, 16:30-17:00 “Sustainable collaboration between Spanish and Swiss Biotech Ecosystems” |
Company profile
AseBio, the Spanish Bioindustry Association, brings together and represents the interests of companies, associations, foundations, universities and technology and research centres that work in the field of biotechnology in Spain.
We collaborate closely with regional, national and European governments, as well as with social organisations that are committed to science and the use of biotechnology to improve people’s lives and promote environmental sustainability, economic development and high value-added employment.
Website: https://asebio.com/
Follow us
https://www.linkedin.com/company/asociacion-espanola-de-bioempresas/mycompany/
3PBiovian
3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors.
Website: https://3pbiovian.com/
Almirall
Through pharmaceutical innovation, investment in R&D and strong commitment to global healthcare partnerships, we develop and commercialize solutions with specific focus on dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis or acne. We care and listen to our patients’ needs. We find solutions for them.
In 2023, we totaled €898,5M of sales through a direct presence in 21 countries (US and EU) and a robust network of regional partners distributing our drugs in 70 additional countries through our 13 global affiliates.
Almirall is listed on the Spanish Stock Exchange (ticker:ALM). We seek building value-creating partnership across the R&D continuum (from early research to late clinical) to make a significant difference in patients’ lives.
Almirall is actively seeking collaborations and breakthrough in-licensing opportunities at any stage of development, including:
• Inflammation and autoimmune diseases (IMID’s)
• Rare skin diseases
• Dermato-oncology diseases
• Other Dermatology indications
Website: www.almirall.com
Basque Health Cluster
Basque Health Cluster, leads the healthcare and life sciences ecosystem in the Basque Country. Our main objective is to coordinate, represent, manage, promote and defend the common interests of our member companies. We encompass the entire value chain of the sector and operate as a driving force of the ecosystem, promoting networking and collaboration, as well as acting as an intermediary between all the agents that operate in it and between the public and private sectors.
Website: https://basquehealthcluster.org/en/
Bflow
Biobide
Biobide is a Contract Research Organization with more than 19 years of experience offering preclinical assays with the Zebrafish New Alternative Model (NAM) for Toxicity and Efficacy screening assays as well as Disease Modeling to Pharmaceutical, Biotech, Chemical, Tobacco and Cosmetic companies.
Bioga
Bioga is a non-profit business association that brings together the organisations integrated in the value chain of the biotechnology sector of Galicia (Spain). The cluster works closely with the private and public sector, the Health System and the Public Administration to improve the competitiveness of the Galician biotechnology sector, seeking business generation and collaborations at a regional, national and international level. Bioga operates around five pillars: public and private funds mobilisation, retention and attraction of talent, hybridisation of sectors for innovation increase, internationalisation, and promotion of digitalisation. Transversally to this, Bioga organises routinely networking and matchmaking activities that boost the visibility of the Galician biotechnology ecosystem and maximise cooperation and business generation.
Website: https://www.bioga.org/en/
BIOINGENIUM
Bioingenium is a preclinical CDMO offering development and manufacturing services for biopharma. We specialize in recombinant protein production using Pichia pastoris, E. coli, and mammalian cells. With over 15 years of experience, we excel in strain engineering, upstream and downstream process development, protein characterization, and process scale-up.
CZ Vaccines
CZ Vaccines, a biopharmaceutical CDMO is an ideal partner for any organization intending to advance their biologic product candidates from development scale to clinical Phase I to III, and commercial supplies capability.
State-of-art technology, with strong technical, development and manufacturing capabilities in VACCINES and THERAPEUTICS. Your partner for BIOLOGICS manufacturing
• Live & Inactivated Bacteria & Viral Vaccines up to BSL-2
• Sterile processing systems
• Process Development / Optimisation (Upstream / Downstream)
• Scale-up and cGMP manufacturing
• Aseptic filling into vials
• Lyophilization (clinical trial material and large scale)
• Quality control testing: Microbiological: Sterility-non-sterility, Chemical-Physical and Biological
• Labeling & packaging
• DS & DP release
• Storage: (+2-8ºC), (-30ºC), (-80ºC)
Website: https://www.czvaccines.com/en/
Diversa Technologies
DIVERSA Technologies pioneers lipid-based nanotechnology to enhance drug delivery and efficacy, delivering innovative therapeutics
Website: https://www.diversatechnologies.com/
Fundación Medina
At MEDINA, we specialize in discovering bioactive molecules from natural sources, driving innovation in pharmaceutical and biotech sectors. With a commitment to excellence and a relentless pursuit of discovery, our expert team combines its deep knowledge in natural product chemistry, high-throughput screening techniques and microbiology to harness the vast chemical diversity within microorganisms and uncover novel bioactive microbial strains and compounds.
Website: https://www.medinadiscovery.com
GalChimia
GalChimia is a CRO specialized in Organic Chemistry that offers services in Discovery, Process, and Analytical Chemistry for the pharma, biotech, and agrochemical industries. The passion for chemistry of our team is reflected in their ability to provide creative solutions to the most challenging syntheses, transforming the company into a European leader in Chemical Synthesis.
Passion for chemistry, powered by research: organic chemistry experts supporting discovery programs in the pharma, biotech, and agrochemical industries.
Website: https://www.galchimia.com/
Gate2 Brain
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We pursue our goals using a radically innovative peptide-based patented technology platform. Gate2Brain is currently looking for co-developments in the CNS space and a lead investor to close our 5,5M€ Seed Round.
Innoprot
Innoprot is a biotechnology company focused on the development of cell-based assays and technologies for drug discovery. Our technology platforms include the Nomad Biosensors, used for multiplexing GPCR screening assays, in vitro models that mimick cellular pathways associated with the main neurodegenerative diseases developed in a wide range of primary and immortalized cell lines.
Liberabio
Libera Bio develops a new family of therapeutics based on its MPN Technology for nanodelivery to intracellular targets and on novel monoclonal antibodies, with the goal of having them commercialized by large biopharma companies.
First technology with in vivo POC of intracellular delivery of whole antibodies.
MPN may combine in a single nanocapsule a mAb and a small molecule.
Libera Bio lead candidates are antibodies for KRAS G12D (LIB111) and KRAS G12V (LIB125) cancer targets, delivered by MPN. Each of these mutations is associated with 1 in 4 pancreatic cancers, 1 in 10 colorectal cancers, etc. Both MPN-mAbs show evidence of efficacy in preclinical models and are ready for IND-enabling studies. Our pipeline includes another 4 mAbs at earlier stages.
We are very open to collaborations to deliver biologics (and small molecules) to intracellular targets, especially in oncology, neurology, virology.
Website: https://www.liberabio.com
ONIRIA THERAPEUTICS, SL
Oniria Therapeutics is a biopharmaceutical company in the field of precision oncology and focused on cancer persistence. It aims to revolutionize cancer treatment by bringing to market first-in-class drugs, designed to address cancer recurrence in solid and liquid aggressive tumors that are unresponsive to current treatments, paving the way for novel therapeutic combinations or standalone treatment. At the same time, Oniria is developing a Companion Diagnostic test to mitigate its flagship product’s clinical trial risks, validating therapeutic effects at the molecular level for each patient.
The company is currently raising a Series A round.
Webside: www.oniriatherapeutics.com
Oryzon
TAD
TAD (The Art of Discovery) is specialized in preclinical evaluation of efficacy and toxicology of drugs, biologics and monoclonal antibodies in unique humanized mouse models of malaria, hematotoxicology, inflammatory bowel disease and soon in cancer. The data obtained in the in vivo models are used to build mathematical models that measure the effect of medication on individuals where each individual is its of control of therapeutic response.
